Higher Logic Announces Plan to Help Organizations Through Coronavirus Concerns with Engagement Platform

WASHINGTON, March 12, 2020 /PRNewswire/ — Higher Logic, the industry-leading SaaS engagement platform of associations and B2B organizations with more than 2.7 billion community interactions annually, announced today that it will offer Event Engagement for free to current and prospective customers facing the challenge of delivering meaningful experiences and engagement during the health crisis of the novel coronavirus (COVID-19).  Leveraging its human-focused engagement platform, Higher Logic will support virtual events to assist in driving engagement and connection for attendees. This program is being provided at no charge to anyone with events scheduled from April 1st to December 31st of 2020.

Higher Logic recognizes that in-person events are a key driver of enriching the customer experience for many organizations and is recommending a way to maximize the impact of a virtual conference. Due to the health concerns of COVID-19, large in-person events like Protech Fusion, SaaStr, Association of University Technology Managers, Facebook F8, the National Comprehensive Cancer Network, and Google I/O have already announced cancellations. Higher Logic is using its engagement expertise to offer solutions for those looking to host their events virtually.

This program will offer organizations the solution they need to organize their event online and facilitate discussions before, during and after the event. Included with this offer are pre-built event templates with specific design features and engagement elements to help facilitate the virtual conference. The goal is to enable the same networking and engagement experience that attendees get on-site at a conference while eliminating the health concerns of a large crowd.

“We know that many organizations are worried about how to get through this difficult time. As a community focused company, we want to do our part to help the global community,” says Chief Executive Officer at Higher Logic, Kevin Boyce. “Offering this program will give organizations the capability to connect and interact with their attendees until they can safely hold large in-person events. It will also demonstrate the value of an online community, connecting customers and members at all times, especially when faced with unforeseen circumstances.”

Organizations looking to support their events with the Higher Logic platform can find more information here.

About Higher Logic
Higher Logic takes a data-driven approach to engagement communities and communication to give organizations an expanded suite of engagement capabilities. From the initial web visit to renewal and ongoing engagement, we help you track and manage interactions along each stage of the customer and member experience. Higher Logic supports 3,000+ customers across 21 countries worldwide. The company was named one of 2018’s 500 fastest growing companies in North America by Deloitte and 2019’s fastest-growing private companies in the U.S. by Inc. 5000.

Media Contact: 
Morghan Cope 
mcope@higherlogic.com  
PR Communications Specialist 
Higher Logic

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/higher-logic-announces-plan-to-help-organizations-through-coronavirus-concerns-with-engagement-platform-301022448.html

SOURCE Higher Logic

Staff

Recent Posts

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health…

35 minutes ago

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment…

35 minutes ago

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…

16 hours ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…

16 hours ago

Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting

Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines…

16 hours ago